Newman Peter J, Newman Debra K
Blood Research Institute, The Blood Center of Southeastern Wisconsin, PO Box 2178, 638 N. 18th St, Milwaukee, Wis 53201, USA.
Arterioscler Thromb Vasc Biol. 2003 Jun 1;23(6):953-64. doi: 10.1161/01.ATV.0000071347.69358.D9. Epub 2003 Apr 10.
Recent studies of platelet endothelial cell adhesion molecule-1 (PECAM-1 [CD31])-deficient mice have revealed that this molecule plays an important role in controlling the activation and survival of cells on which it is expressed. In this review, we focus on the complex cytoplasmic domain of PECAM-1 and describe what is presently known about its structure, posttranslational modifications, and binding partners. In addition, we summarize findings that implicate PECAM-1 as an inhibitor of cellular activation via protein tyrosine kinase-dependent signaling pathways, an activator of integrins, and a suppressor of cell death via pathways that depend on damage to the mitochondria. The challenge of future research will be to bridge our understanding of the functional and biochemical properties of PECAM-1 by establishing mechanistic links between signals transduced by the PECAM-1 cytoplasmic domain and discrete cellular responses.
最近对血小板内皮细胞黏附分子-1(PECAM-1 [CD31])缺陷小鼠的研究表明,该分子在控制其表达细胞的激活和存活中发挥着重要作用。在这篇综述中,我们聚焦于PECAM-1复杂的胞质结构域,并描述目前已知的其结构、翻译后修饰及结合伴侣。此外,我们总结了相关研究结果,这些结果表明PECAM-1是通过蛋白酪氨酸激酶依赖性信号通路抑制细胞激活的因子、整合素的激活剂以及通过依赖线粒体损伤的途径抑制细胞死亡的因子。未来研究的挑战将是通过建立由PECAM-1胞质结构域转导的信号与离散细胞反应之间的机制联系,来加深我们对PECAM-1功能和生化特性的理解。